{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-161592","form_type":"8-K","ticker":"FBRX","cik":"0001419041","company_name":"Forte Biosciences, Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.332829+00:00","generated_at":"2026-06-01T04:17:10.989854+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Forte settles shareholder suit; board expands to 9, Camac appoints 2 directors, poison pill expires July 2024","bullets":["Board expands to nine seats; one incumbent director resigns; two Camac-selected directors appointed from five-company-identified candidates.","Strategic alternatives committee formed including Camac nominees; rights plan expires July 12, 2024, not renewed, no new plan for 3 years.","Camac enters standstill/voting agreement through 2028; company pays $364k for Camac's 2023 proxy contest out-of-pocket expenses.","Settlement resolves claims that July 2023 private placement (~$25M) was intended to entrench board and block Camac director nominees.","The standstill prohibits Camac from acquiring additional shares, launching proxy contests, or seeking board representation until 2028."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-161592","json":"https://secwatch.observer/filing/0001193125-24-161592.json","markdown":"https://secwatch.observer/filing/0001193125-24-161592.md","text":"https://secwatch.observer/filing/0001193125-24-161592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419041/000119312524161592/0001193125-24-161592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419041/000119312524161592/d826178d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:17:10.989854+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}